Childhood and adolescent cancers

HR-NBL2

High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
  • Open at Paris since : 10/07/2020
  • Target : Child
  • Phase : Phase III

Trial description

This is an international multicenter, open-label, randomized phase III trial including three sequential randomizations to assess efficacy of induction and consolidation chemotherapies and radiotherapy for patients with high-risk neuroblastoma.
Url of the trial

Main investigator